Open Access Highly Accessed Pre-publication history

Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes

George Pentheroudakis*, Vassiliki Kotoula, Wendy De Roock, George Kouvatseas, Pavlos Papakostas, Thomas Makatsoris, Demetris Papamichael, Ioannis Xanthakis, Joseph Sgouros, Despina Televantou, Georgia Kafiri, Athanassios C Tsamandas, Evangelia Razis, Eleni Galani, Dimitrios Bafaloukos, Ioannis Efstratiou, Iliada Bompolaki, Dimitrios Pectasides, Nicholas Pavlidis, Sabine Tejpar and George Fountzilas

BMC Cancer 2013, 13:49  doi:10.1186/1471-2407-13-49

Pre-publication versions of this article and reviewers' reports

Original Submission - Version 1 Manuscript 01 Sep 2012
Reviewer's Report Jeffrey Evans 08 Oct 2012
Reviewer's Report Murali Bashyam 27 Oct 2012
Resubmission - Version 2 Manuscript Author's comment 14 Nov 2012
Reviewer's Report Murali Bashyam 02 Dec 2012
Editorial acceptance 30 Jan 2013
Published 02 Feb 2013